Lenz Therapeutics stock rises after FDA approves presbyopia eye drops

Go back to Lenz Therapeutics stock rises after FDA approves presbyopia eye drops
(NASDAQ: LENZ) Delayed: 3.92 +0.20 (5.38%)
Previous Close $3.72    52 Week High $ 
Open $3.75    52 Week Low $ 
Day High $4.00    P/E N/A 
Day Low $3.66    EPS $ 
Volume 923,820